CLINICAL_TRIALS
trial_result
· 2021-02-17
Clinical Trial Update: A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia [Phase 2]
Summary
Phase 2 trial update for ATR-101 in congenital adrenal hyperplasia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millendo Therapeutics, Inc. | Conditions: Congenital Adrenal Hyperplasia | Phase 2 | Status: COMPLETED | Results posted: 2021-02-17